Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

One-year Graft Patency after Coronary Artery Bypass Surgery

관상동맥우회술 후 1년 개존성에 관한 연구

  • Kim, Gi-Bong (Dept.of thoracic and Chrdiovascular Surgery Seoul National University College of Medicine) ;
  • Kim, Hyeon-Jo (Dept.of thoracic and Chrdiovascular Surgery Seoul National University College of Medicine) ;
  • Seong, Gi-Ik
  • 김기봉 (서울대학교 의과대학 흉부외과학교실) ;
  • 김현조 (서울대학교 의과대학 흉부외과학교실) ;
  • 성기익
  • Published : 1997.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Between July 1994 and August 1995, 78 patients underwent coronary artery bypass graft at Seoul National University Hospital. Coronary angiogram was performed one year after coronary artery bypass graft in 49 patients(62.8%) for evaluation of the graft patency and analysis of the risk factors for graft occlusion. The patency rates of both the internal mammary artery and the radial artery grafts were 100% , although three internal mammary artery grafts(5.0%) were narrowed(string sign). And that of the saphenous vein grafts were 85.2%. Multivariate analysis for the preoperative, operative, and postoperative factors was done between the widely patent and the narrowed internal mammary artery graft groups, and between the patent and the occluded saphenous vein graft groups by the general linear models procedure. Patient's age($\geq$60 years), postoperative intraaortic balloon pump insertion, bleeding, and acute renal failure were found to be the significant risk factors for internal mammary artery graft narrowing, and coronary artery size(< 1.5 mm) was the significant risk factor for the saphenous vein graft occlusion (p<0.05) . This study confirms that the arterial graft is superior to the vein graft at one-year patency rate, and suggests the risk factors for graft occlusion during the first postoperative year. Knowledge of this study may provide a basis for estimating the risk factors for graft occlusion, and thereby modifying surgical strategy and postoperative surveillance.

1994년 7월부터 1995년 8월까지 서울대학교병원 흉부외과에서 시행한 관상동맥 우회술 78례 중 49례 (62,8%)에서 수술 1년 후 관상동맥 조영술을 시행하여 이식 혈관의 개존성을 조사하였으며, 수술 전,후 및 수술과 관련된 여러 위험 요소들이 개존성에 미치는 영향에 대하여 분석하였다. 관상동맥 우회술 후 평균 13.4$\pm$2.1개월 째에 관상동맥 조영술을 시행하였다. 내유동맥으로 문함을 시행한 60개소 중 3개소에서 string sign을 보였으나, 폐쇄 없이 전례에서 개존성이 유지되었으며, 요골동맥으로 문합을 시행한 4개소는 모두 개존성이 유지되었다. 복제정맥으로 문합을 시행한 81개소 중 69개소(85.2%)에서 개존성이 유지되었으며, 12개 소(14.8%)에서 폐쇄되었다. 개존성에 미치는 위험요소로 수술 전,수술 중 그리고 합병증 등의 수술 후 요소로 나누어 일원적 및 다원적으로 분석하였으며, 내유동맥의 협착 과 복재정맥의 개존성, 폐쇄에 미치는 요소들을 분석하였다. 내유동맥은 환자의 연령(60세 이상),수술 후 대동맥 내 풍선펌프의 삽입,수술 후 출혈, 및 급성신부전 등 합병증이 이식 혈관의 협착과 관련된 위험 인자였으며, 복제정맥은 우회술을 시\ulcorner 받은 관상동맥의 직경이 1.5mm 이하인 경우가 이식 혈관의 폐쇄 위험성과 관련된 위험 인자로 분석되었다(p<0.05). 관상동맥 우회술 1년 후 이식 혈관의 개존성은 내유동맥이 복재정맥보다 우수함을 보였으며 환자 연령 수술 후 대동맥 내 풍선펌프의 삽입여부, 출혈, 급성 신부전 등의 합병증 및 문합된 관상 동맥의 직경 등이 개존에 관련된 요소로 분석되었다. 이러한 결과를 토대로 수술 후 이식혈관의 폐쇄 여부에 대한 11측과 수술 방법이나 수술 후 환자의 추적 관찰에 도움을 줄 수 있으리라 생각된다.

Keywords

References

  1. Circulation v.68 Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery: survival data CASS Principal Investigators and their Associates
  2. Br Med J v.294 What contribution has cardiac surgery made to the decline in mortality from coronary heart disease? Neutze JM;White HD
  3. Circulation v.90 A comparison of internal mammary artery and saphenous vein graft after coronary artery bypass surgery: no difference in Ⅰ-year occlusion rates and clinical outcome van der Meer J;Hillege HL;van Gilst WH(et al.)
  4. Circulation v.89 Long-term graft patency (3 years) after coronary artery surgery: effect of aspirin results of a VA Cooperative study Goldman S;Copeland J;Moritz T(et al.)
  5. 대흉외지 v.25 관상동맥우회술 후 이식혈관의 개존 노환구;박영환;장병철(등)
  6. Circulation v.68 no.SUP.Ⅱ Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks. 1 year, 5 to 7 years, and 10 to 12 years after surgery Campeau L;Enjalbert M;Lesperance J;Vaislic C;Grondin CM;Bourassa MG
  7. Circulation v.70 no.SUP.Ⅰ Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation Grondin CM;Campeau L;Lesperance J;Enjalbert M;Bourassa MG
  8. Circulation v.90 Patency of internal thoracic artery graft: comparison of right versus left and importance of vessel grafted Chow M;Sim E;Orszulak TA;Schaff H
  9. J Thorac Cardiovasc Surg v.111 Effect of competitive blood flow on artery graft patency and diameter: medium-term postoperative follow-up Hashimoto H;Isshiki T;Ikari Y(et al.)
  10. J Am Diet Asso v.85 Health implications of obesity: an NIH consensus development conference Burton BT;Foster WR
  11. Eur J Cardio-thorac Surg v.7 Optimal antithrombotic theraphy following aortocoronary bypass: A meta-analysis Fremes SE;Levinton C;Naylor CD;Chen E;Christakis GT;Golman BS
  12. J Am Coll Cardiol v.24 Effect of low dose aspirin (50mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting : patency and clinical outcome at 1 year Meer J;Riviere AB;Gilst WH(et al.)
  13. J Thorac Cardiovasc Surg v.107 Effects of antiplatelet theraphy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting Rajah SM;Nair U;Rees M(et al.)
  14. Am J Cardiol v.74 Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting Eritsland J;Arnesen H;Seljeflot I(et al.)
  15. Ann Thorac Surg v.57 Effect of chronic native flow competition on internal thoracic artery grafts Lust RM;Zeri RS;Spence PA(et al.)
  16. J Thorac Cardiovasc Surg v.86 The left internal mammary artery as a sequential graft to the left anterior descending system McBride LR;Barner HB
  17. J Thorac Cardiovasc Surg v.107 Arterial revascularization with the right gastroepiploic artery and internal mammary arteries in 300 patients Grandjean JG;Boonstra PW;Heyer P;Ebels T
  18. J Thorac Cardiovasc Surg v.107 Aprotinin for coronary bypass oprations: Efficacy, safety, and influence on early saphenous vein graft patency Lemmer JH;Stanford W;Bonney SL(et al.)